Cargando…
A Novel Therapeutic Approach to Treat Alzheimer’s Disease by Neurotrophic Support During the Period of Synaptic Compensation
Alzheimer’s disease (AD), at present, is considered an incurable disease and a major dilemma with no drug to stop or slow down its progression. Drugs that are currently available in the market are able to only transiently improve the clinical symptoms. The repeated failures in developing an effectiv...
Autores principales: | Baazaoui, Narjes, Iqbal, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870029/ https://www.ncbi.nlm.nih.gov/pubmed/29562539 http://dx.doi.org/10.3233/JAD-170839 |
Ejemplares similares
-
Alzheimer’s Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound
por: Baazaoui, Narjes, et al.
Publicado: (2022) -
Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound
por: Baazaoui, Narjes, et al.
Publicado: (2017) -
Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction
por: Wei, Wei, et al.
Publicado: (2021) -
Inhibition of AMD-Like Pathology With a Neurotrophic Compound in Aged Rats and 3xTg-AD Mice
por: Liu, Yinghua, et al.
Publicado: (2019) -
Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease
por: Kazim, Syed Faraz, et al.
Publicado: (2016)